BILLINGS KBEAR WEATHER

Health

Pfizer to spend $11.6B on migraine treatment maker Biohaven

Pfizer is starting to put its COVID-19 cash influx to use by spending $11.6 billion to venture deeper into a new treatment area


Go to Source
Author:

thebear

May 10th, 2022

No comments

Comments are closed.